|
|
|
Volumn 10, Issue 8, 2007, Pages 543-548
|
|
BioLOGIC Europe 2007 - Terrapinn's eighth annual conference
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
ALEMTUZUMAB;
ALPHA INTERFERON;
ALPHEON;
ALTEPLASE;
AMG 220;
BEVACIZUMAB;
BI 204;
HUMAN GROWTH HORMONE;
LOW MOLECULAR WEIGHT HEPARIN;
MONOCLONAL ANTIBODY;
NATALIZUMAB;
PANITUMUMAB;
RANIBIZUMAB;
RITUXIMAB;
TENECTEPLASE;
TGN 1412;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
VALTROPIN;
VECTIBIX;
ATHEROSCLEROSIS;
BIOLOGICAL ACTIVITY;
BIOLOGICAL THERAPY;
BREAST CANCER;
CONFERENCE PAPER;
CROHN DISEASE;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MARKETING;
DRUG SAFETY;
ECONOMIC ASPECT;
HEART INFARCTION;
HUMAN;
IMMUNOGENICITY;
MEDICAL TECHNOLOGY;
NONHODGKIN LYMPHOMA;
NONHUMAN;
RETINA MACULA AGE RELATED DEGENERATION;
SINGLE DRUG DOSE;
ANTIBODIES, MONOCLONAL;
BIOLOGICAL THERAPY;
DRUG APPROVAL;
DRUG INDUSTRY;
EUROPE;
HUMANS;
INFLAMMATORY BOWEL DISEASES;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MACULAR DEGENERATION;
NEOPLASMS;
PATENTS;
RECOMBINANT PROTEINS;
UNITED STATES;
|
|
EID: 34547518810
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
